Treating bladder cancer with ARID1A gene changes
Targeting ARID1A mutated Urothelial Carcinoma
This project will develop new treatment approaches for people with bladder cancer whose tumors have changes in the ARID1A gene.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Salt Lake City Healthcare System NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11213965 on NIH RePORTER |
What this research studies
Researchers are focusing on bladder cancers that carry mutations in the ARID1A gene, a change linked to recurrence and resistance to therapy. They will study tumor samples from Veterans alongside laboratory models to learn how ARID1A loss helps cancer cells survive and resist treatment. The team will look for weaknesses created by ARID1A mutations and test drugs or drug combinations that exploit those weaknesses in preclinical experiments. Promising approaches may be advanced toward testing in patients at the VA medical center.
Who could benefit from this research
Good fit: Ideal candidates would be adults with bladder (urothelial) cancer whose tumor testing shows an ARID1A mutation, likely able to receive care through the Salt Lake City VA system.
Not a fit: People whose tumors do not have ARID1A mutations or who have non-bladder cancers are unlikely to benefit from these specific approaches.
Why it matters
Potential benefit: If successful, this work could lead to targeted therapies that overcome treatment resistance in ARID1A-mutant bladder cancer.
How similar studies have performed: Some preclinical work in other cancers suggests ARID1A-related vulnerabilities can be targeted, but there are currently no approved therapies specific to ARID1A-mutant tumors, so this approach is partly novel.
Where this research is happening
Salt Lake City, United States
- VA Salt Lake City Healthcare System — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Gupta, Sumati — VA Salt Lake City Healthcare System
- Study coordinator: Gupta, Sumati
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.